Patents by Inventor Marie-Claire Janin-Bussat

Marie-Claire Janin-Bussat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunocytokines for the treatment of cancer
    Patent number: 11673931
    Abstract: The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: June 13, 2023
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Peter Lowe, Jean-François Haeuw, Alicia Contet, Céline Bertaux, Barbara Akla, Marie-Claire Janin-Bussat, Martine Malissard, Juliette Trepreau
  • Universal method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
    Patent number: 11340233
    Abstract: The present invention relates to a new method for capturing and analysing antibody-drug conjugates (ADCs) in biological samples, such as e.g., serum. Methods for analysing the structure of an antibody-drug conjugate (ADC) in a biological sample and methods for assessing the stability of an ADC are also provided.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: May 24, 2022
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Christine Klinguer-Hamour, Marie-Claire Janin-Bussat
  • NEW IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER
    Publication number: 20220048966
    Abstract: The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
    Type: Application
    Filed: September 30, 2019
    Publication date: February 17, 2022
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Peter LOWE, Jean-François HAEUW, Alicia CONTET, Céline BERTAUX, Barbara AKLA, Marie-Claire JANIN-BUSSAT
  • IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER
    Publication number: 20200308242
    Abstract: The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
    Type: Application
    Filed: April 1, 2020
    Publication date: October 1, 2020
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Peter LOWE, Jean-François HAEUW, Alicia CONTET, Céline BERTAUX, Barbara AKLA, Marie-Claire JANIN-BUSSAT
  • A NEW UNIVERSAL METHOD TO CAPTURE AND ANALYZE ADCS FOR CHARACTERIZATION OF DRUG DISTRIBUTION AND THE DRUG-TO-ANTIBODY RATIO IN BIOLOGICAL SAMPLES
    Publication number: 20190079099
    Abstract: The present invention relates to a new method for capturing and analysing antibody-drug conjugates (ADCs) in biological samples, such as e.g., serum. Methods for analysing the structure of an antibody-drug conjugate (ADC) in a biological sample and methods for assessing the stability of an ADC are also provided.
    Type: Application
    Filed: March 7, 2017
    Publication date: March 14, 2019
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Christine KLINGUER-HAMOUR, Marie-Claire JANIN-BUSSAT
  • NOVEL ANTI-CXCR4 ANTIBODY AND ITS USE FOR THE DETECTION AND DIAGNOSIS OF CANCER
    Publication number: 20170234879
    Abstract: The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer.
    Type: Application
    Filed: November 8, 2016
    Publication date: August 17, 2017
    Inventors: Christine KLINGUER-HAMOUR, Alexandra JOUHANNEAUD, Marie-Claire JANIN-BUSSAT
  • Anti-CXCR4 antibody and its use for the detection and diagnosis of cancer
    Patent number: 9518120
    Abstract: The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer. In particular, the antibody of the invention recognizes monomeric and homodimeric CXCR4, but not heterodimeric CXCR4.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: December 13, 2016
    Assignee: Pierrre Fabre Medicament
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Marie-Claire Janin-Bussat
  • NOVEL ANTI-CXCR4 ANTIBODY AND ITS USE FOR THE DETECTION AND DIAGNOSIS OF CANCER
    Publication number: 20140170681
    Abstract: The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer.
    Type: Application
    Filed: July 30, 2012
    Publication date: June 19, 2014
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Marie-Claire Janin-Bussat